What should I do if I experience nausea when I increase my dose
Phase 2 trial dosage groups and weight loss results The Phase 2 trial randomized 338 adults with obesity (BMI 30 or higher, or BMI 27-30 with at least one weight-related condition) into seven groups
Analysis of plasma biochemistry Plasma alanine transaminase (ALT), aspartate aminotransferase (AST), triglyceride, total cholesterol, and glucose levels were measured enzymatically using a Clinical Analyzer 7180 (Hitachi High-Technologies, Tokyo, Japan)
A Safety Data Sheet and a brief handling reference are included alongside the COA in the package
Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG , Walsh GL, Putnam JB Jr
W., Rosenkilde, M